Molecular imaging of adrenal neoplasms

被引：15

作者：

Chen, Clara C. ^{[3
]}

Carrasquillo, Jorge A. ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Mol Imaging & Therapy Serv, New York, NY 10021 USA

[2] Weill Cornell Med Ctr, Dept Radiol, New York, NY USA

[3] NIH, Div Nucl Med, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2012年 / 106卷 / 05期

关键词：

MIBG; somatostatin; FDG; fluorodopa; pheochromocytoma; neuroblastoma; POSITRON-EMISSION-TOMOGRAPHY; HIGH-RISK NEUROBLASTOMA; I-123 METAIODOBENZYLGUANIDINE SCINTIGRAPHY; 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE; PROSPECTIVE MULTICENTER TRIAL; INRG TASK-FORCE; FOLLOW-UP; F-18-FDG PET/CT; ADRENOCORTICAL CARCINOMA; SOMATOSTATIN RECEPTORS;

D O I：

10.1002/jso.23162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The adrenal glands are complex structures from which a variety of benign and malignant tumors may arise and are a common site of metastatic disease. Several radiopharmaceuticals are used for imaging the adrenals, including I-123/I-131 metaiodobenzylguanidine (MIBG), norcholesterol derivatives, In-111 pentetreotide and Ga-68 somatostatin analogs, [F-18]fluorodeoxyglucose, [F-18]fluorodopa, [F-18]fluorodopamine, C-11 meta hydroxyephedrine, and C-11/F-18/I-123 Metomidate (MTO) or its analogs. In this review we focus on the role of these reagents in metastatic lesions, cortical neoplasms, pheochromocytoma/paraganglioma, and neuroblastoma (NB). J. Surg. Oncol. 2012; 106:532542. (C) 2012 Wiley Periodicals, Inc.

引用

页码：532 / 542

页数：11

共 112 条

[1] THE IMPACT OF I-123 METAIODOBENZYLGUANIDINE SCINTIGRAPHY ON DIAGNOSTICS AND FOLLOW-UP OF NEUROBLASTOMA [J].

ABRAHAMSEN, J ;

LYCK, B ;

HELGESTAD, J ;

FREDERIKSEN, PB .

ACTA ONCOLOGICA, 1995, 34 (04) :505-510

[2]

ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO

[3]

2-7

[4] Somatostatin receptor gene expression in neuroblastoma [J].

Albers, AR ;

O'Dorisio, MS ;

Balster, DA ;

Caprara, M ;

Gosh, P ;

Chen, F ;

Hoeger, C ;

Rivier, J ;

Wenger, GD ;

O'Dorisio, TM ;

Qualman, SJ .

REGULATORY PEPTIDES, 2000, 88 (1-3) :61-73

[5] 18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation [J].

Ansquer, Catherine ;

Scigliano, Sonia ;

Mirallie, Eric ;

Taieb, David ;

Brunaud, Laurent ;

Sebag, Frederic ;

Leux, Christophe ;

Drui, Delphine ;

Dupas, Benoit ;

Renaudin, Karine ;

Kraeber-Bodere, Francoise .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (09) :1669-1678

[6] Practical Considerations in the Evaluation and Management of Adrenocortical Cancer [J].

Balasubramaniam, Sanjeeve ;

Fojo, Tito .

SEMINARS IN ONCOLOGY, 2010, 37 (06) :619-626

[7] FDG-PET in adrenocortical carcinoma [J].

Becherer, A ;

Vierhapper, H ;

Pötzi, C ;

Karanikas, G ;

Kurtaran, A ;

Schmaljohann, J ;

Staudenherz, A ;

Dudczak, R ;

Kletter, K .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (04) :289-295

[8]

Bergström M, 2000, J NUCL MED, V41, P275

[9] 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas:: CT and MRI correlation [J].

Bhatia, Kunwar S. S. ;

Ismail, Mohamed M. ;

Sahdev, Anju ;

Rockall, Andrea G. ;

Hogarth, Kieran ;

Canizales, Ana ;

Avril, Norbert ;

Monson, John P. ;

Grossman, Ashley B. ;

Reznek, Rodney H. .

CLINICAL ENDOCRINOLOGY, 2008, 69 (02) :181-188

[10] Characterization of Adrenal Masses by Using FDG PET: A Systematic Review and Meta-Analysis of Diagnostic Test Performance [J].

Boland, Giles W. L. ;

Dwamena, Ben A. ;

Sangwaiya, Minal Jagtiani ;

Goehler, Alexander G. ;

Blake, Michael A. ;

Hahn, Peter F. ;

Scott, James A. ;

Kalra, Mannudeep K. .

RADIOLOGY, 2011, 259 (01) :117-126

← 1 2 3 4 5 6 7 8 9 10 →